Purcell AR, Zhen XM, Wong J, Glastras SJ, et al. Glucagon-like peptide-1 receptor agonist treatment reduces body weight and improves glycaemic outcomes in patients with concurrent overweight/obesity and type 1 diabetes: A systematic review and meta-analysis. Diabetes Obes Metab 2026;28:296-305.
PMID: 41334580